wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

MC610 EXAM II

Total questions: 177

Worksheet time: 2hrs 18mins

Name
Class
Date
1.

Possible effects of viral infection are

a)

Oncogenic mutation

b)

Cell destruction (lysis)

c)

Budding viruses

d)

Dormant infection (latent infection)

2.

Influenza virus is

(a)  

3.

Influenza virus has a few RNA polymerases. Which of the following is a drug target due to its cap-dependent endonuclease activity?

a)

PB1

b)

PB2

c)

Polymerase acidic (PA) protein

d)

Neuraminidase

e)

Hemagglutinin

4.

Influenza A virus has two spike protein components

(a)  

5.

This spike protein interacts with sugar component of the cell surface, which is essential for virus entry

(a)  

6.

This spike protein is an enzyme that breaks down glycosidic bonds, which aids in release of mature viral particles

(a)  

7.

This is a gradual change in antigenicity due to point mutations that affect major antigenic sites on glycoprotein (HA & NA)

(a)  

8.

This is an abrupt change caused by genetic exchange of viral DNA following co-infection of an animal by two different influenza viruses

(a)  

9.

After virus is breathed in and binds to airway epithelial cells using Hemagglutinin (HA). HA binds to "this" on the surface of host cells.

(a)  

10.

Released vRNA can be transcribed into proteins necessary for viral assembly, and also replicated by RNA polymerase. This is called:

(a)  

11.

This blocks the release of new influenza virus by breaking the bond between sialic acid and galactose. This is only effective in early onset of infection (within 48 hours)

(a)  

12.

Neuraminidase (NA) cleaves a glycosidic bond of sialic acid to form this. NA is this inhibitor that prevents release of mature viruses

(a)  

13.

This is advanced NA inhibitor from Zanamivir: 1. Prodrug for better oral BA, 2. Removal of guanidino group, 3. Addition of alkyl chain

(a)  

14.

What is a drug target of viral replication inhibitor for influenza A? (Hint: this is needed for mRNA stability, export, and translation)

(a)  

15.

This is a viral replication inhibitor for influenza A virus. This drug is converted by hydrolysis to baloxavir acid. Single dose be administered within 48 hours of symptoms, and Ca, Fe, and antacids may impair absorption

(a)  

16.

Which of the following DNA virus types does infect epithelial cell & establish latent infection in neurons? (Type 1 is associated with oropharyngeal lesions while type 2 infects genital mucosa)

a)

Cytomegalovirus (CMV)

b)

Varicella-Zoster Virus

c)

Herpes Simplex Virus (HSV)

17.

T/F: Drugs for Herpesvirdae (DNA virus) is only effective when it's in active stage, not in dormant as the viruses can remain latent within the body over long periods of time and reactive to cause new infection when in active stage

(a)  

18.

What are the key enzymes for Herpes virus to translate viral proteins to make structural proteins, viral enzymes, and regulatory proteins?

a)

Hemagglutinin

b)

HSV thymidine kinase

c)

Neuraminidase

d)

HSV DNA polymerase

19.

Acyclovir lacks this for another connection to growing deoxy ribose-PO4 backbone, which leads to DNA chain termination

(a)  

20.

This is a L-valyl ester of acyclovir used in similar fashion, but shows better oral BA

(a)  

21.

This is a prodrug that must be converted to penciclovir through hydrolysis and oxidation, with similar indications to acyclovir

(a)  

22.

These are deoxythymidine mimics that inhibit thymidylate synthase as they have an isosteric replacement of thymidine's methyl group

a)

Trifluridine

b)

Vidarabine

c)

Idoxuridine

23.

Selective toxicity of oseltamivir is due to:

a)

Activation by viral enzymes

b)

Selectivity uptaken by viral cells

c)

Inhibiting a target unique to viruses

d)

Being a prodrug

24.

Ganciclovir is similar to acyclovir but CMV lacks viral thymidine kinase. Instead, CMV expresses this which selectively activates (or phosphorylates) the drug in infected cells

(a)  

25.

Ganciclovir has more SEs compared to acyclovir. Why?

a)

Because it is not a prodrug

b)

Because it targets CMV not Herpes virus

c)

Because its triphosphate can interfere with human DNA polymerase activity

26.

What is this?

1. This is a deoxythymidine mimic

2. This has an isostere of thymidine's methyl group

3. This can cause elevated mutagenesis, which leads its use to topical

4. This is approved for Tx of primary keratoconjunctivitis

(a)  

27.

This is a guanine mimic, with a sugar with an error. This is being incorporated into the viral DNA after being triphosphorylated, causing chain termination. This is use parenterally and as an ophthalmic gel in herpetic keratitis. What is this?

a)

Valganciclovir

b)

Ganciclovir

c)

Cidofovir

d)

Foscarnet

28.

Name the drug used only for ganciclovir-resistant CMV viral infections but cause nephrotoxicity

(a)  

29.

Name the drug used only for ganciclovir-resistant CMV viral infections but cause nephrotoxicity, hypocalcemia, renal impairment and seizures

(a)  

30.

Name the drug: this is a new class of anti-CMV drug that is not a DNA polymerase inhibitor. Instead, the drug inhibits CMV DNA terminase complex which is required for viral DNA processing and packaging. For this reason it is not associated with bone marrow suppression or nephrotoxicity!

(a)  

31.

Pick the DNA polymerase inhibitor

a)

Acyclovir

b)

Oseltamivir

c)

Tenofovir alafenamide fumarate

d)

Ritonavir

32.

Pick the transition state inhibitor

a)

Raltegravir

b)

Abacavir

c)

Oseltamivir

d)

Ganciclovir

33.

Which of the following antivirals targets DNA processing after viral DNA replication is completed (i.e. DNA terminase complex)?

(a)  

34.

Could agents used in influenza be effective in HIV treatment?

a)

Yes, they both use RNA as the genetic material

b)

No, they have different life cycles

c)

Depends on the specific agent

35.

Human Immunodeficiency Virus (HIV) is

(a)  

36.

Treatment goals for highly active Antiretroviral therapy (HIV therapy) are

a)

Suppress HIV load

b)

Increase CD4+ T cells

c)

Minimize development of viral resistance

d)

Minimize drug toxicity

37.

What is this class?

1. This class is a nucleoside analogue with an error sugar

2. This class is a competitive inhibitor, taken up by cells and phosphorylated by our nucleoside/tide kinases to the triphosphate form, ultimately leading to chain termination due to the absence of 3'-hydroxyl group

3. Resistance rapidly occurs to this class when used as single agents

a)

NNRTIs (Non-nukes)

b)

NRTIs (Nukes)

c)

Protease Inhibitors ("-navirs")

d)

Integrase Inhibitors ("-tegravirs")

38.

Which of the following NRTIs is cytosine analog?

a)

Abacavir

b)

Lamivudine

c)

Emtricitabine

d)

Tenofovir disoproxil

39.

Which of the following NRTIs is guanosine analog?

a)

Abacavir

b)

Lamivudine

c)

Emtricitabine

d)

Tenofovir disoproxil

40.

Which of the following NRTIs is adenosine analog?

a)

Abacavir

b)

Lamivudine

c)

Emtricitabine

d)

Tenofovir disoproxil

41.

What is this?

1. This is a purine analogue, metabolized via alcohol dehydrogenase and glucuronidation, so less of a concern with DDIs

2. Serious hypersensitivity reactions may occur, especially in patients with HLA-B*5701 allele, which requires patient to be screened prior to initiating therapy

3. Other ADRs include lactic acidosis, coronary heart disease

a)

Abacavir

b)

Lamivudine

c)

Emtricitabine

d)

Tenofovir disoproxil

42.

What is in (A)?

TDF can cause decreased BMD, due to a higher plasma concentration of the active drug as compare to TAF. TAF is a (A), which is more stable in plasma as compared to the phosphonate of TDF, allowing for more of the prodrug entering the target

(a)  

43.

This class bind to allosteric sites (non-competitive inhibitor) on reverse transcriptase and alter enzyme active site. This class shows synergistic effects with nucleoside analogs, used in combo

(a)  

44.

Which of the classes has the following SE profiles?

1. This may have significant interactions with other drugs: All inhibit, and several induce CYP450s (eg. CYP3A family and CYP2B6)

2. Some drugs may prolong QT interval and patients may experience CNS symptoms including dizziness, insomnia, drowsiness, vivid dreams, and nightmares

3. DDIs with PPIs and other acid reducing medications

a)

NRTI

b)

Protease Inhibitor

c)

Integrase Inhibitor

d)

NNRTI

45.

Name this drug:

- This is a newest agent that does not require CD4 counts or any restrictions for its use

- This shows a better SE profile, such as QT prolongation, rashes and CNS effects

- This shows no DDIs with PPIs

- This shows little cross resistance with other NNRTIs and better outcome in combo with other classes

(a)  

46.

Why are NRTI combo always analogs of different bases?

a)

Avoid competition for activation (phosphorylation)

b)

Avoid competition for incorporation into daughter viral DNA

c)

Enhance suppression of viral replication (synergy)

d)

Delay onset of resistance

47.

Name this enzyme:

- HIV proteins are synthesized together as one long continuous protein and this enzyme cleaves the precursor protein into individual, functional proteins needed to build a new virus. Without this final processing step, HIV cannot form new infectious virions.

- This enzyme is an aspartyl, essential for its activity, that cleaves viral peptide precursors

- Inhibitors are transition-state analogues, designed as peptide mimics, with non-hydrolyzable isoeteres in place of the amide bond. The inhibitors are always given with 2 reverse transcriptase inhibitors

(a)  

48.

Those are protease inhibitors. What is that in the circles?

(a)  

49.

Which of the following drug classes are transition state inhibitors?

a)

DNA polymerase inhibitors

b)

Neuraminidase inhibitors

c)

Protease inhibitors

d)

Integrase inhibitors

e)

NRTIs

50.

Which of the following is a prodrug and requires phosphorylation by a viral-specific kinase or phosphotransferase? (Hint: UL97 kinase)

a)

Cidofovir

b)

Sofosbuvir

c)

Foscarnet

d)

Ganciclovir

51.

What are common SE effect profile present in all HIV Protease inhibitors?

a)

Nephrotoxicity

b)

Hepatotoxicity

c)

Alteration of glucose and lipid metabolism

d)

Lipodystrophy

52.

Name an alternative PK booster but not as a protease inhibitor

(a)  

53.

Name this protein:

This binds to specific sequence in viral genome (LTR: long terminal repeats), cleaving DNA, and inserts the viral DNA to host DNA

(a)  

54.

What is the MOA of integrase inhibitors?



(a)  

55.

This class of drugs should not be administered with antacids, vitamins, or minerals because the drugs are inhibiting their target by chelating a divalent cation in the active site, which results in prevention of integration of viral DNA into host DNA

- Now considered first line therapy along with 2 reverse transcriptase inhibitors

(a)  

56.

Name this drug: This is a fusion inhibitor peptide that is used parentally

(a)  

57.

Name this drug: This is a CCR5 receptor antagonist; HIV entry via GPCR binding

(a)  

58.

Which of the following antivirals targets DNA processing after viral DNA replication is completed (i.e. DNA terminase complex)?

a)

Darunavir

b)

Efavirenz

c)

Letermovir

d)

Foscarnet

59.

The reason that ritonavir is almost always given with other protease inhibitors

a)

It has a different mechanism of action that leads to synergistic effects

b)

It has a different mechanism of action that lowers the risk of resistance

c)

It improves their oral absorption

d)

It acts as a pharmacokinetic booster

60.

Which type of hepatitis viruses is +ssRNA virus?

a)

Hepatitis A virus

b)

Hepatitis B virus

c)

Hepatitis C virus

61.

Which type of hepatitis viruses is +ssRNA virus and no treatment/drugs to cure?

a)

Hepatitis A virus

b)

Hepatitis B virus

c)

Hepatitis C virus

62.

Which type of hepatitis viruses is DNA virus that is converted to a cccDNA in the host cell?

a)

Hepatitis A virus

b)

Hepatitis B virus

c)

Hepatitis C virus

63.

In HBV, relaxed dsDNA is transported to the nucleus where our DNA repair factor create "this" that persists in the nucleus, then transcribed into all the different mRNAs encoded by HBV genome

(a)  

64.

This is a drug target of HBV that has reverse transcriptase activity that copies RNA to DNA (vRNA → vDNA). For this reason some NRTIs are useful for HBV infections

(a)  

65.

True/False: Severe, acute exacerbation of hep B may occur upon discontinuation of anti-hep B therapy

a)

True

b)

False

66.

True/False: HBV polymerase inhibitors (ie. Reverse Transcriptase Activity Inhibitor) may cause development of HIV NRTI drug resistance in chronic Hep B patients with unrecognized or untreated HIV infection

a)

True

b)

False

67.

Name this drug:

1. This is a first line agent, used as IM or IV injection, some nasal spray

2. This drug is used to treat HBV and HCV

3. This drug induces transcription of INF-stimulated genes (ISGs) via the Jak/Stat signaling pathway

4. Pegylated form improves PK properties

(a)  

68.

Interferons "interfere" with viral replication by:

a)

Inhibiting the replication and transcription and translation of mRNA into viral nucleic acid

b)

Degrading RNA

c)

Blocking translation of proteins

d)

Blocking virus maturation

e)

Upregulating major histocompatibiliyy complex (MHC) molecules

69.

In lifecycle of Hep C, the virus attaches to receptor on surface of liver cells and endocytosed into the cell, and releases +RNA genome → endoplasmic reticulum → translated and generates a long polypeptide where encodes 2 proteases, which are a drug target. What are they?

(a)  

70.

This is one of the core proteins (RNA replication cofactor) that are essential for replication. This complex cofactor (or structural scaffold type protein) facilitates the formation of the replication complex, which becomes a drug target in HCV therapy

(a)  

71.

This converts the +RNA into -RNA and uses that as a template to generate many copies of +RNA, which becomes a drug target in HCV therapy

(a)  

72.

Name the drug: this drug mimics purine ribonucleoside (purine with error) used in old therapy before DDAs emerged and a prodrug that is phosphorylated by cellular adenosine kinase. This drug inhibits viral RNA polymerase but highly mutagenic and teratogenic. This should always be used in combo

(a)  

73.

NS3/4A protease inhibitors are metabolized by this CYP isoform so all PIs depend in this CYP relevant metabolism

a)

CYP2C9

b)

CYP3A4

c)

CYP2C19

d)

CYP2D6

74.

Which of the following drugs does NOT have the MOA that prevents NS5A protein from promoting RNA replication and viral assembly. (NS5A is a replication complex protein essential for RNA polymerase activity and viral assembly)

a)

Daclatasvir

b)

Velpatasvir

c)

Paritaprevir

d)

Ledipasvir

75.

Which of the following drugs does NOT have the MOA by which inhibits NS5B polymerase in HCV, leading to inhibition of RNA synthesis and termination of replication?

a)

Daclatasvir

b)

Dasabuvir

c)

Paritaprevir

d)

Sofosbuvir

76.

Name the drug:

1. This drug is effective against all HCV genotypes

2. This drug is a nucleotide analog and a prodrug that forms free phosphate (same principle as tenofovir)

3. This drug causes chain termination due to the steric groups at the 2' position (F, fluorine)

4. This drug is used in combo with NS5A polymerase inhibitors and NS3/N4 PIs

5. This drug is NUKE



(a)  

77.

Name the drug:

1. This drug is non-nucleoside

2. This drug is used in combo with NS5A polymerase inhibitors along with ritonavir and in some cases with ribavirin

3. This drug is non-NUKE



(a)  

78.

Monoclonal antibodies against spike proteins (-mabs) are given IV and they block entry into cells and help kill infected cells. They are used for Tx of mild to moderate COVID-19 patients at high risk for progression to serious disease and death.

T/F: They are NOT effective in patients who are already hospitalized with severe COVID-19

a)

True

b)

False

79.

What is the advantage of antiviral drugs over other approaches to treat COVID-19?

a)

Better efficacy

b)

Effective against emerging variants

c)

Better price

d)

Better PK profile

80.

This drug was developed for Ebola virus, but it was found ineffective, and it was shown to be useful in SARS and MERS instead. This is a phosphoramidate prodrug that inhibits RNA-dependent RNA polymerase, leading to competing with ATP and delaying a chain termination. What is this?

a)

Molnupiravir

b)

Sofosbuvir

c)

Remdesivir

d)

Paxlovid

81.

Name this drug:

1. This drug was developed for influenza virus, but abandoned due to adverse effect, and developed later for SARS CoV2.

2. This drug is an ester prodrug of N4-hydroxycytidine (ie. nucleoside analog) that is phosphorylated to triphosphate nucleotide, gets incorporated into RNA, which results in inhibition of replication and lethal mutations.

3. Some concerns for emergence of dangerous variants and possible mutations to human genome are raised and this drug may harm the fetus.

a)

Molnupiravir

b)

Sofosbuvir

c)

Remdesivir

d)

Paxlovid

82.

Name this drug:

1. This drug is tripeptide and mimics one of the viral endogenous substrate peptides. When activated, nitrile group forms covalent bond with 3CL protease.

2. This drug is used in combo with ritanovir (PK booster) for high-risk patients to prevent progression to severe COVID-19, including hospitalization or death.

3. This drug must be given immediately or within five days of diagnosis.

a)

Molnupiravir

b)

Sofosbuvir

c)

Remdesivir

d)

Paxlovid

83.

Pick the prodrugs

(a)  

84.

Pick the prodrugs

(a)  

85.

Which of the following species is known most lethal that it infects all stages of erythrocytes and creates greatest parasite load?

a)

P. vivax

b)

P. falciparum

c)

P. ovale

d)

P. malariae

86.

In malaria lifecycle, plasmodium-infected female Anopheles mosquito bites skin and plasmodium sporozoites enter bloodstream. Then, sporozoites attack hepatocytes and undergo asexual replication, then produces liver stage "this". What is this?

(a)  

87.

In erythrocyte stage, infected hepatocytes rupture and these are released into blood and infect RBCs. Inside RBCs, these are developed to ring forms (trophozoites). What are these as one of the antimalarials' drug target?

(a)  

88.

In erythrocyte stage, some merozoites mature into these to infect new mosquitoes. What are these as one of the antimalarials' drug target?

(a)  

89.

Which of the following species is known to be able to maintain hepatocyte infection as a dormant form known as the hypnozoite?

a)

P. vivax

b)

P. falciparum

c)

P. ovale

d)

P. malariae

90.

After the initial exoerythrocytic stage, P. falciparum and P. malariae are no longer found in the liver. P. vivax and P. ovale, however, can maintain hepatocyte infection as a dormant form known as the this. What is this as one of the antimalarials' drug target?

(a)  

91.

What are the potential ways to control malaria?

a)

Elimination of vector

b)

Drug therapy

c)

Vaccination

92.

Which of the following antimalarials is NOT drugs that target parasites residing in erythrocytes (ie. blood schizonticides) so not effective for the RBC stage?

a)

Quinoline alkaloids (-quine)

b)

Atovaquone-Proguanil

c)

Artemisinin

d)

Primaquine

93.

Quinoline drugs gets inside the food vacuole and gets trapped in the acidic environment. Then, it inhibits toxic heme converted to nontoxic this so heme accumulates, eventually causing rupture of parasites as well as RBC. What is this?

(a)  

94.

Quinoline drugs have SAR of

a)

quinoline nucleus

b)

EWG on second ring

c)

EDG on first ring

d)

Basic amines

95.

Quinoline drugs are (_) charged inside food vacuole, which trap them inside after entering through pores of the vacuole.

a)

Positively

b)

Negatively

96.

Resistance is achieved if mutations to this gene alter composition of the pores in food vacuole, thus no longer positively charged, which efflux the drug from the intracellular digestive vacuole, where is site of action. Name the gene.

(a)  

97.

Due to development of resistance that pumps out a drug targeting, chloroquine is ineffective against most strains of this species.

a)

P. vivax

b)

P. falciparum

c)

P. ovale

d)

P. malariae

98.

What are the SEs of Chloroquine?

a)

Retinopathy

b)

QT prolongation

c)

Skin rash, SJS

d)

Severe hypotension, respiratory & cardiac arrest

99.

Which of the following is NOT the SE of Quinine?

a)

Hyperglycemia

b)

QT prolongation

c)

Drug-induced immune thrombocytopenia

d)

Neuromuscular blocking activity

e)

Cinchonism

100.

Which of the following quinoline drugs has BBW for history of depression, generalized anxiety disorder, psychosis, or schizophrenia?

a)

Quinine

b)

Chloroquine

c)

Hydroxychloroquine

d)

Mefloquine

101.

Which of the following CYP isoforms mainly metabolizes quinoline drugs: Quinine, Chloroquine, Mefloquine, etc.?

a)

CYP2D6

b)

CYP3A4

c)

CYP2B6

d)

CYP2C19

102.

What is this?

This generates oxygen radicals within the digestive vacuole where plenty of oxygen and heme coexist. With the highly oxidative environment in the parasite, these agents produce various oxygen radicals that target many of the essential proteins and nucleic acids

(a)  

103.

What is this called? (Hint: Artemisinin and oxygen radicals)

(a)  

104.

This drug inhibits Plasmodium mitochondrial electron transport chain indicated for prophylaxis and treatment of chloroquine-resistant malaria

a)

Atovaquone-Proguanil

b)

Quinine

c)

Artemisinin

d)

Primaquine

105.

This is a tissue schizonticide that eliminate developing or dormant liver forms relevant to P. vivax and P. ovale only; thus, the drug is not effective for the RBC stage. The MOA is still unclear but it is believed its metabolites create oxygen species which interfere with Plasmodium ETC.

a)

Atovaquone-Proguanil

b)

Quinine

c)

Artemisinin

d)

Primaquine

106.

This causes drug-induced anemia in patients with glucose-6-phosphate dehydrogenase deficiency that results in decreased NADPH and GSH synthesis making the cell more sensitive to oxidative agents leading to hemolysis.

a)

Atovaquone-Proguanil

b)

Quinine

c)

Artemisinin

d)

Primaquine

107.

Chloroquine only eliminates parasites in RBCs, not liver.

a)

True

b)

False

108.

 Mr. G is 36 y.o. Married software engineer who was born and raised in India. He comes to the US and is completely well for 6 months. He then begins to experience episodes of fever, headache, and body aches. One week later, he goes to his physician, who examines a smear of Mr.G’s blood, diagnoses malaria, and prescribes chloroquine for treatment. Therapy with chloroquine resolves his symptoms completely. However, Mr.G notes recurrence of fevers and other symptoms 3 months later and returns to his doctor’s office. What is likely explanation for the return of Mr.G’s fever?

a)

Infection with P. vivax

b)

Infection with P. falciparum

c)

Infection with P. ovale

d)

Infection with P. malariae

109.

 Mr. G is 36 y.o. Married software engineer who was born and raised in India. He comes to the US and is completely well for 6 months. He then begins to experience episodes of fever, headache, and body aches. One week later, he goes to his physician, who examines a smear of Mr.G’s blood, diagnoses malaria, and prescribes chloroquine for treatment. Therapy with chloroquine resolves his symptoms completely. However, Mr.G notes recurrence of fevers and other symptoms 3 months later and returns to his doctor’s office. And it is more likely due to infection with either P. vivax or P. ovale. How can Mr. G's treatment be modified so that his illness will not return?

a)

Mefloquine

b)

Primaquine

c)

Atovaquone-Proguanil

d)

Artemisinin

110.

Which of the following statements is NOT correct for Chagas Disease?

a)

Caused by Trypanosoma cruzi

b)

Needs to be treated early before progression to chronic form

c)

Parasite is transmitted through bites of the bug

d)

Causes cardiomyopathy, megacolon, megaesophagus

111.

Which of the following drugs are used for drug treatment in Chagas disease by the MOA that they are activated to nitro radical anions leading to formation of oxygen radicals that damage parasites?

a)

Chloroquine

b)

Artemisinin

c)

Pyrimethamine

d)

Benznidazole

112.

Which agent is trapped inside the parasite organelle?

a)

Chloroquine

b)

Artemisinin

c)

Pyrimethamine

d)

Benznidazole

113.

Trypanosoma cruzi is particularly sensitive to drugs (Benznidazole and Nifurtimox) due to inefficient detoxification capabilities while mammalian cells poorly activate drug and detoxify oxygen radicals

a)

True

b)

False

114.

Benznidazole and Nifurtimox are safe in pregnant women

a)

True: they are known to be safe in pregnancy

b)

False: patient should avoid during pregnancy due to potential for fetal-embryo toxicity, genotoxicity, carcinogenicity, and mutagenicity

115.

Patients on Benznidazole and Nifurtimox should avoid alcohol use as disulfiram effects

a)

True

b)

False

116.

This drug is given to patients who are infected in Toxoplasmosis. The MOA of the drug is selectively inhibiting parasite dihydrofolate reductase, which interferes with folate synthesis pathway.

(a)  

117.

This drug is given to patients who are infected in Toxoplasmosis. The MOA of the drug is selectively inhibiting parasite dihydrofolate reductase, which interferes with folate synthesis pathway.

(a)  

118.

This drug is given to patients who are infected in Toxoplasmosis. The MOA of the drug is selectively inhibiting dihydropteroate synthase that humans don't have and plays a key role in first step of folate synthesis?

(a)  

119.

Pyrimethamine has a SE profile that causes dose-dependent myelosuppression, and this SE is prevented with this drug that reduces side effects related to folate deficiency in the patients

(a)  

120.

Which of the following adverse effects is NOT in SE profile of Sulfadiazine?

a)

Hypersensitivity (Rash)

b)

Severe hypersensitivity (SJS)

c)

Hemolytic anemia in G6PD deficient patients

d)

Dose-dependent myelosuppression

121.

Hemolytic anemia is one of the side effects in G6PD deficient patients who are on Sulfadiazine. What would they need to detox sulfonamide metabolites of the drug?

(a)  

122.

What is this drug?

This drug has a nitro group that serves as an electron acceptor, forming reduced cytotoxic compounds that damage DNA, resulting in death of the protozoal trophozoites (anaerobic pyruvate metabolism)

a)

Sulfadiazine

b)

Pyrimethamine

c)

Metronidazole

d)

Tinidazole

e)

Leucovorin

123.

Metronidazole and Tinidazole acquire a selectivity for killing parasites not human cells as the parasites activates the drugs while humans do not

a)

True

b)

False

124.

Which of the following statements is NOT correct for metronidazole and tinidazole?

a)

Indications are Giardiasis, Trichomoniasis, and Amebiasis

b)

Potential mutagens

c)

May change color of urine to red or brown due to excretion of colored metabolites

d)

DDIs with alcohol due to disulfiram like reaction

e)

Should avoid in all stages of pregnancy

125.

Name the parasitic infection:

1. Caused by Giardia lamblia that causes diarrheal illness

2. Acquired by contact with feces containing this species cysts from infected ones

3. Drinking contaminated water is common method of transmission

4. Prominent clinical manifestations are diarrhea, malabsorption, damage to the GIT

5. Drug treatment options are metronidazole and tinidazole

(a)  

126.

Name the parasitic infection:

1. Caused by Entamoeba histolytica

2. Acquired by ingesting the infectious parasite cyst

3. Trophozoites invade into the colonic mucosa resulting in colitis and bloody diarrhea

4. Many individuals remain asymptomatic but excrete the infectious cyst form (transmission)

5. Drug treatment options are metronidazole and tinidazole

(a)  

127.

Name the parasitic infection:

1. Common STI caused by Trichomonas vaginalis

2. Increase risk to HIV and other STDs

3. In women, it causes vaginal discharge and pruritus

4. In men, usually asymptomatic but can cause urethritis

5. Drug treatment options are metronidazole and tinidazole

(a)  

128.

Mebendazole and Albendazole have the SAR two structures that perform the following MOAs:

1. Prevents cell division in worms by interfering with microtubule assembly

2. Irreversibly blocks glucose uptake, thereby depleting glycogen stored in the parasite but do not affect glucose metabolism or bind to mammalian tubulin in the host (ie. selectivity to worms not human cells)

a)

Benzimidazole

b)

Sulfonamide

c)

Carbamate

d)

Epoxide

129.

Which of the following ADRs does belong to a SE profile of mebendazole and albendazole?

a)

Teratogenicity

b)

Bone marrow suppression in long-term use

c)

Hepatotoxicity in long-term use

d)

Hypersensitivity

130.

Name the drug:

This drug is a depolarizing neurotransmitter blocking agent that causes spastic paralysis in worms and released from the intestinal tract.

Additionally, AChE inhibition of the drug adds to its neuromuscular blocking activity, and it exerts a local action in the GTI as poorly absorbed

a)

Praziquantel

b)

Albendazole

c)

Pyrantel Pamoate

d)

Ivermectin

131.

Name the drug:

This drug is a depolarizing neurotransmitter blocking agent that causes spastic paralysis in worms and released from the intestinal tract.

Additionally, AChE inhibition of the drug adds to its neuromuscular blocking activity, and it exerts a local action in the GTI as poorly absorbed

a)

Praziquantel

b)

Albendazole

c)

Pyrantel Pamoate

d)

Ivermectin

132.

Name the drug:

This drug is used for infections caused by schistosomes. The drug increases cell membrane permeability resulting in the influx of extracellular calcium, which causes massive contractions and ultimate paralysis, followed by detachment from blood vessel walls and phagocytosis. Rapidly metabolized by CYP3A4.

a)

Praziquantel

b)

Albendazole

c)

Pyrantel Pamoate

d)

Ivermectin

133.

Name the drug:

This drug is used for onchocerciasis (river blindness) and used in strongyloidiasis (thread worm disease). The drug only kills microfilariae not adult worms. The drug is a strong allosteric modulator of the glutamate-gated chloride ion channels, which are important in invertebrate nerve and muscle cells (not expressed in humans). Hyperpolarization follows due to an increase in chloride ion permeability, leading to muscle paralysis and eventually cell death of the worms

a)

Praziquantel

b)

Albendazole

c)

Pyrantel Pamoate

d)

Ivermectin

134.

What is this transporter? Ivermectin does not readily cross BBB as expelled by this transporter encoded by MDR1, so CNS effects are limited. The drug are however contraindicated in conditions associated with impaired BBB (e.g., meningitis). At high doses, ivermectin can cause toxic neurologic effect under MDR1 gene mutation.

(a)  

135.

Which of the following agents show selective toxicity due to attacking a unique target to worms?

a)

Albendazole

b)

Pyrantel pamoate

c)

Praziquantel

d)

Ivermectin

136.

Which of the following is the example of Intrinsic Resistance to antimicrobial agents?

a)

Gram negative bacteria envelope as a barrier

b)

Porin with only 1% permeability that does not allow antibiotics to enter

c)

Rigid outer membrane that does not allow diffusion

d)

Efflux systems

e)

Beta-lactamase encoded genome

137.

Name this process of acquiring resistance:

Bacteria can take up DNA released from lysed bacterial cells. It is then integrated into a homologous region on the recipient genome. In other words, homologous region is required

a)

Transformation

b)

Transposon

c)

Conjugation

d)

Transduction

e)

Gene Regulation

138.

Name this process of acquiring resistance:

Chromosomal fragment of DNA that can be translocated from one bacterial cell to another even in absence of homologous sequence (ie. hopping gene)

a)

Transformation

b)

Transposon

c)

Conjugation

d)

Transduction

e)

Gene Regulation

139.

Name this process of acquiring resistance:

R-plasmid is transferred from one bacteria to another via an appendage known as pilus (R+ to R-; Mating). The plasmid may contain multiple antibiotic-resistant genes, and particularly common in Gram (+) bacteria

a)

Transformation

b)

Transposon

c)

Conjugation

d)

Transduction

e)

Gene Regulation

140.

Name this process of acquiring resistance:

Transfer of genes via bacteriophages that invade bacterial cells, integrate their own DNA into the bacterial chromosome, and replicate forming new phages. During its release from the chromosome, it may pick up a resistant gene and transfer it to other cells that it invades

a)

Transformation

b)

Transposon

c)

Conjugation

d)

Transduction

e)

Gene Regulation

141.

Name this process of acquiring resistance:

Regulators of several resistant genes on the bacterial chromosomes are only activated by the presence of antibiotics. Eg. the efflux system along with reduced permeability of several antimicromial agents is activated by the presence of only one of these agents, leading to MDR species

a)

Transformation

b)

Transposon

c)

Conjugation

d)

Transduction

e)

Gene Regulation

142.

Primary mechanism of Antibiotic Resistance are

a)

Preventing access by decreased uptake

b)

Efflux pump by increased elimination

c)

Drug-Inactivation enzymes

d)

Modification of target (ie. alternation in target molecule)

143.

Which of the following statements is NOT TRUE for gram negative bacteria?

a)

Stained in pink color

b)

Drug needs to get through the porin channels

c)

Have a very hydrophobic outer membrane layer

d)

Drug can diffuse through cell wall

144.

These bacteria grow in both aerobic and anaerobic, but GREATER growth in presence of O2 (e.g., E.coli)

a)

Obligate Aerobes

b)

Facultative Anaerobes

c)

Obligate Anaerobes

d)

Aerotolerant Anaerobes

e)

Microaerophiles

145.

This agent inhibits bacterial growth but do not kill bacteria. It is preferred agent in immunocompromised patients. Name this type of antibacterial agents

(a)  

146.

Agents with a broad spectrum may be appropriate for empiric therapy of life-threatening infections, whereas narrow spectrum is preferred for definitive therapy (know the pathogen causing disease)

a)

True

b)

False

147.

Which of the following types of hypersensitivity can be life-threatening, has an immediate onset, IgE-mediated, lasting hours with symptoms of hives, edema, and anaphylaxis?

a)

Type I

b)

Type II

c)

Type III

d)

Type IV

148.

This type of hypersensitivity is complement-mediated that cause immune complex disease, "serum sickness", vasculitis, and nephritis

a)

Type I

b)

Type II

c)

Type III

d)

Type IV

149.

Which of the following types of hypersensitivity can be life-threatening, has an immediate onset, IgE-mediated, lasting hours with symptoms of hives, edema, and anaphylaxis?

a)

Type I

b)

Type II

c)

Type III

d)

Type IV

150.

This type of hypersensitivity is RBC-mediated that cause hemolytic anemia, thrombocytopenia, and antibody-dependent cell killing lasting days (delayed onset).

a)

Type I

b)

Type II

c)

Type III

d)

Type IV

151.

This type of hypersensitivity is Delayed T cell-mediated that maculopapular rashes, SJS, and nephritis

a)

Type I

b)

Type II

c)

Type III

d)

Type IV

152.

Which of the following statements is NOT TRUE for effects on antibiotic on normal bacterial flora?

a)

Collateral damage by antibiotics results from disruption of normal flora

b)

Change in microflora population recovers eventually in complete level

c)

Permits opportunistic bacteria to overpopulate and cause new disease

d)

Permits the growth of drug resistant bacteria

153.

Antibiotic-associated colitis/diarrhea is often caused by infection with C. difficile. Name the two exotoxins that cause diarrhea and inflammation resulting in damage to the colon.

a)

TcdA

b)

TcdB

c)

TcdC

d)

TcdD

154.

Antibiotic-associated colitis/diarrhea is often caused by infection with C. difficile. Which of the following antibiotics are most associated with C. difficile infections?

a)

Fluoroquinolones

b)

Clindamycin

c)

Broad spectrum beta lactams

d)

Cephalosporins

155.

This gram positive coccus is (1) part of the normal microflora of the female genital tract and perineum and (2) 2nd most common cause of UTIs in sexually active young women (honeymoon cystitis)

a)

Staphylococcus aureus

b)

Staphylococcus epidermidis

c)

Staphylococcus saprophyticus

156.

This gram positive coccus is (1) found on the skin and in the nose of healthy people, (2) typically resistant to penicillins, and (3) cause many common bacterial infections in humans like skin and soft tissue infections

a)

Staphylococcus aureus

b)

Staphylococcus epidermidis

c)

Staphylococcus saprophyticus

157.

This gram positive coccus is (1) part of the normal skin microflora, (2) has an ability to form biofilms on plastic devices (major virulence factor), and (3) is a common cause of infection that appears in patients with indwelling catheters and prosthetic devices

a)

Staphylococcus aureus

b)

Staphylococcus epidermidis

c)

Staphylococcus saprophyticus

158.

This gram positive coccus is normal microflora in the mouth and associated with dental infections and cavities. This species cause diseases such as Endocarditis (heart valve infection) following dental procedures or infection when displaced into the bloodstream.

a)

Streptococcus agalactiae

b)

Streptococcus pyogenes

c)

Viridans Streptococcus

d)

Streptococcus pneumoniae

159.

This gram positive coccus has "cell wall antigen" (M protein) that prevents complement activation and inhibits phagocytosis by immune cells. Also, this species cause diseases, such as strep throat, skin infections, scarlet fever & toxic shock caused by pyrogenic exotoxin, and rheumatic heart disease.

a)

Streptococcus agalactiae

b)

Streptococcus pyogenes

c)

Viridans Streptococcus

d)

Streptococcus pneumoniae

160.

This gram positive coccus is normal microflora in the GIT and cause diseases (of childbirth) such as infection in vagina (mom) can lead to meningitis, pneumonia, sepsis in the newborn. For adults, it can cause serious invasive infections in older poeple.

a)

Streptococcus agalactiae

b)

Streptococcus pyogenes

c)

Viridans Streptococcus

d)

Streptococcus pneumoniae

161.

This gram positive coccus colonizes the upper respiratory tract and its polysaccharide capsule prevents bacteria from being phagocytized. This species can cause diseases such as Meningitis, Pneumonia, Middle ear infection in children, etc.

a)

Streptococcus agalactiae

b)

Streptococcus pyogenes

c)

Viridans Streptococcus

d)

Streptococcus pneumoniae

162.

This bacterial species is typically resistant to Penicillins:

1. Most produce Penicillinase (beta-lactamase that destroys Penicillin and Amoxicillin)

2. Use penicillinase-resistant penicillin or add beta-lactamase inhibitor or use cephalosporin (natural penicillinase-resistant)

3. May be resistant to ALL beta-lactams due to acquisition of altered transpeptidase (penicillin binding protein, PBP2a); eg. MRSA or MRSE

a)

Staphylococcus

b)

Streptococcus

c)

Enterococcus faecalis and faecium

163.

This bacterial species are susceptible to Penicillin G and V except this pneumoniae that expresses low affinity penicillin binding proteins making penicillins less effective

a)

Staphylococcus

b)

Streptococcus

c)

Enterococcus faecalis and faecium

164.

This bacterial species are inherently resistant to most beta-lactams, especially cephalosporins and have acquired resistance to Vancomycin (VRE)

a)

Staphylococcus

b)

Streptococcus

c)

Enterococcus faecalis and faecium

165.

This bacterial species is associated with food poisoning and can invade macrophages, endothelial cells and proliferate, eventually entering bloodstream and through placenta of pregnant women. Also, it is inherently resistant to cephalosporins whereas Ampicillin is effective due to higher affinity for target enzyme.

a)

Staphylococcus aureus

b)

E. coli

c)

Listeria monocytogenes

d)

Bacteroides fragilis

e)

Helicobacter pylori

166.

This is an anaerobic gram negative, spiral shaped, microaerophilic species that have 2-7 flagella that increase its motility through viscous mucus layer of stomach. This species produce urease which hydrolyzes gastric urea to form ammonia and CO2. NH3 neutralizes gastric acid and forms a protective "neutral pH cloud" around the organism and infects the protective tissue that lines the stomach and duodenum causing inflammation that result in peptic ulcer disease. Also, this species increases risk for gastric cancer and gastric mucosa-associated tissue lymphoma (MALT lymphoma)

a)

Bacteroides fragilis

b)

Helicobacter pylori

c)

Enterobacteriaceae

167.

Bacillus species (typically aerobic) survive in the environment by spore formation, and spores can survive for decades. This is caused by inoculation of Bacillus anthracis spores (from infected animals) into skin, bacteria germinate and produce a multiprotein exotoxin.

(a)  

168.

This is an anaerobic gram negative species that leads cause local injury allowed by oxygen tolerance and a polysaccharide capsule when displaced beyond mucosal barriers. The local injury includes formation of intra-abdominal abscesses and entering the bloodstream may result in abscess formation in other organs. This species isolates almost always produce beta-lactamse, which not only inactivates penicillins but other beta-lactams, such as many cephalosporins.

a)

Bacteroides fragilis

b)

Helicobacter pylori

c)

Enterobacteriaceae

169.

This is an anaerobic gram negative species with rod shaped and facultative anaerobe that is part of normal GI flora. Some species are important etiologic agents of diarrhea and E. coli, Proteus mirabilis, Klebsiella pneumoniae are EPK pathogen that most commonly cause UTI. Klebsiella species are responsible for many hospital-acquired infections and many of this species produce beta-lactamases that destroy all beta-lactam drugs

a)

Bacteroides fragilis

b)

Helicobacter pylori

c)

Enterobacteriaceae

170.

This is an aerobic gram negative diplococci that is a major cause of meningitis and bacteremia

a)

Neisseria meningitidis

b)

Neisseria gonorrhoeae

171.

This is an aerobic gram negative diplococci that is the cause of gonorrhea and has acquired drug resistance to Sulfonamides, Penicillin (beta-lactamase), fluoroquinolones due to mutation of target. 3rd generation cephalosporins are only effective treatment.

a)

Neisseria meningitidis

b)

Neisseria gonorrhoeae

172.

This is an aerobic gram negative and human pathogen of respiratory tract. This causes many childhood infections, including meningitis, bacteremia, pneumonia, cellulitis, otitis media, conjunctivitis, sinusitis, and acute epiglottis. Type b of this species causes the worst disease, especially in children bacteremia and meningitis which can be protected by vaccination. Other strains can cause invasive infections in children and may cause up to half of serious infections in adults, and often express beta-lactamases that inactivate Amoxicillin.

a)

Haemophilus influenzae

b)

Pseudomonas aeruginosa

173.

This is an aerobic gram negative species that cause 10-20% of all nosocomial (hospital associated) disease. This species is ubiquitous in environment, forming biofilms and causes infections when immune defenses are disrupted: burn wound infections, IV or urinary catheters, and neutropenia. This can persist in the lungs of cystic fibrosis patients, and is a leading cause of ventilator-associated pneumonia (VAP). Multidrug resistance has become a major issue in management of hospital-acquired infections with this species due to (1) acquisition of beta-lactamases, (2) porin channel mutations, and (3) efflux pumps.

a)

Haemophilus influenzae

b)

Pseudomonas aeruginosa

174.

Atypical bacteria lack this in their cell wall, typically intracellular parasites, so antibiotics that target cell wall synthesis (beta-lactams, vancomycin, etc.) are ineffective. They require special staining methods to detect presence, The examples are Mycoplasma pneumoniae and Chlamydia.

(a)  

175.

This atypical bacteria lack peptidoglycan and causes community-acquired pneumonia especially in younger patients, and is the cause of atypical or walking pneumonia.

a)

Mycoplasma pneumoniae

b)

Chlamydia

176.

This atypical bacteria is gram negative but have very little peptidoglycan in cell wall. It is an obligate intracellular pathogens that cause STI or community-acquired pneumonia that mirrors the other species in its person-to-person transmission, clinical features, and treatment is less common

a)

Mycoplasma pneumoniae

b)

Chlamydia

177.

This atypical bacterial pathogen is a gram negative aerobic bacillus that has a very thin peptidoglycan layer, and is not easily stained using the gram staining method. It causes outbreaks due to poorly maintained artificial water systems. It can replicate inside human cells within membrane bound vesicles. Beta-lactams and aminoglycosides are not effective in treating diseases caused by this pathogen.

a)

Mycoplasma pneumoniae

b)

Chlamydia

c)

Legionella pneumophila